A Cambridge PhD discovery raised £1.5M led by SCVC to fix gene therapy's costly flaw — TFN

Houdini Bio has raised about £1.5M in grants and pre-seed funding led by SCVC to improve gene therapy durability. The Cambridge startup uses software to redesign therapeutic DNA so cells don’t switch it off.

Raccontata datechfundingnews.com